The Myelin Repair Foundation Enters First International Partnership With Bionure, Inc.

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SARATOGA, Calif. & BARCELONA, Spain--(BUSINESS WIRE)--The Myelin Repair Foundation (MRF) and Bionure, Inc. today entered a collaborative partnership agreement to advance therapeutics development for Multiple Sclerosis (MS). The Foundation’s unique Accelerated Research Collaboration™ (ARC™) model facilitates collaboration between the top MS leaders worldwide to advance promising compounds into the clinic. In this agreement, the Myelin Repair Foundation will work closely with Bionure, Inc. to assess the neuroprotective capabilities that will promote myelin repair of the company’s proprietary MS therapeutic compound, BN201.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC